VI
RNAM

Versor Investments’s Avidity Biosciences RNAM Stock Holding History

Versor Investments’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-162,880
Closed -$11.7M – 469
2025
Q4 		$11.7M Buy
+162,880
New +$10.5M 1.83% 9

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Versor Investments's RNAM Position: Q1 2026 in Review

Versor Investments sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 162,880 shares — an estimated $11.7M sold.

Versor Investments first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $11.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Versor Investments reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 162,880 Avidity Biosciences shares in Q1 2026, an estimated $11.7M.
  • Versor Investments first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Versor Investments's Avidity Biosciences position peaked at $11.7M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.